Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek

Nuclear Medicine and Biology

Volumn 34, Issue 7, 2007, Pages 849-853

  Wallace, Anne M ^a,b   Hoh, Carl K ^b,c   Darrah, Denise D ^b   Schulteis, Gery ^d   Vera, David R ^b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of California   (United States)

Author keywords

99mTc DTPA; Breast cancer; Mannosyl dextran lymphoseek; Molecular imaging; Radiopharmaceutical; Sentinel lymph node biopsy

Indexed keywords

LYMPHOSEEK; PENTETATE TECHNETIUM TC 99M; PENTETIC ACID MANNOSYL DEXTRAN; RADIOPHARMACEUTICAL AGENT; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; BLOOD TOXICITY; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG SAFETY; FEMALE; HALF LIFE TIME; HUMAN; LYMPHOSCINTIGRAPHY; MOLECULAR IMAGING; PHASE 1 CLINICAL TRIAL; RADIOACTIVITY; RASH; REVIEW; SENTINEL LYMPH NODE BIOPSY; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DEXTRANS; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; LYMPH NODES; LYMPHATIC METASTASIS; MANNANS; METABOLIC CLEARANCE RATE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PENTETIC ACID; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TISSUE DISTRIBUTION;

EID: 34848846914     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.05.003     Document Type: Review

References (14)

1. 99mTc]DTPA-mannosyl-dextran. J Nucl Med 42 (2001) 951-959
2. Ellner S.J., Mendez J., Vera D.R., Hoh C.K., Ashburn W.L., and Wallace A.M. Sentinel lymph node mapping of the colon and stomach using Lymphoseek in a pig model. Ann Surg Oncol 11 (2004) 674-681
3. Mendez J., Wallace A.M., Hoh C.K., and Vera D.R. Detection of gastric and colonic sentinel nodes via endoscopic administration of Lymphoseek in pigs. J Nucl Med 44 (2003) 1677-1681
4. Wallace A.M., Ellner S.J., Mendez J., Hoh C.K., Salem C.E., Bosch C.M., et al. Minimally invasive sentinel lymph node mapping of the pig colon with Lymphoseek. Surgery 139 (2006) 217-223
5. Salem C.E., Wallace A.M., Hoh C.K., and Vera D.R. A preclinical study of prostate sentinel node mapping with Lymphoseek. J Urol 175 (2006) 744-748
6. Steer C.J. Receptor-mediated endocytosis: mechanism, biologic function, and molecular properties. In: Zakim D., and Boyer T.D. (Eds). Hepatology: a textbook of liver disease (1996), W. B. Saunders, Philadelphia 49-214
7. Wallace A.M., Hoh C.K., Vera D.R., Darrah D., and Schulteis G. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Ann Surg Oncol 10 (2003) 531-538
8. 99mTc]DTPA-mannosyl-dextran for breast cancer sentinel node mapping. Nucl Med Biol 30 (2003) 805-810
9. Wallace A.M., Hoh C.K., Ellner S.J., Darrah D.D., Schulteis G., and Vera D.R. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping. Ann Surg Oncol 14 (2007) 913-921
10. 99mTc]DPTA-mannosyl-dextran. Nucl Med Biol 30 (2003) 457-464
11. Linehan D.C., Hill A.D.K., Akhurst T., Yeung H., Yeh S., Tran K.N., et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 6 (1999) 450-454
12. McMasters K., Wong S., Martin R.I., Chao C., Tuttle T., Noyes R., et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multi-institutional study. Ann Surg 233 (2001) 676-687
13. Schoder H., Glass E.C., Pecking A.P., Harness J.K., Wallace A.M., Hirnle P., et al. Molecular targeting of the lymphovascular system for imaging and therapy. Cancer Metastasis Rev 25 (2006) 185-201
14. Yeung H., Cody III H.S., Turlakow A., Riedel E.R., Fey J., Gonen M., et al. Lymphoscintigraphy and sentinel node localization in breast cancer patients: a comparison between 1-day and 2-day protocols. J Nucl Med 42 (2001) 420-423